Koyfin Home > Directory > Health Care > Acceleron Pharma > Other Liabilities

Acceleron Pharma Other Liabilities Chart (XLRN)

Acceleron Pharma annual/quarterly Other Liabilities from 2012 to 2020.
  • Acceleron Pharma Other Liabilities for the quarter ending June 06, 2020 was $4m a 60.92% increase of 2m year over year
  • Acceleron Pharma Other Liabilities for the last 12 months ending June 06, 2020 was $4m a 60.92% increase of 2m year over year
  • Acceleron Pharma Annual Other Liabilities for 2019 was $2m a -108.62% decrease of -2m from 2018
  • Acceleron Pharma Annual Other Liabilities for 2018 was $4m a -86.34% decrease of -3m from 2017
  • Acceleron Pharma Annual Other Liabilities for 2017 was $7m a 18.21% increase of 1m from 2016
Other Balance Sheet Metrics:
  • Acceleron Pharma Total Assets for the quarter ending September 09, 2018 was $338m a -15.10% decrease of -51m year over year
  • Acceleron Pharma Total Equity for the quarter ending September 09, 2018 was $319m a -14.45% decrease of -46m year over year
View Chart On Koyfin

Quarterly XLRN Other Liabilities Data

06/2020$4m
03/2020$3m
12/2019$2m
09/2019$1m
06/2019$2m
03/2019$2m
12/2018$4m
09/2018$4m
06/2018$4m
03/2018$3m

Annual XLRN Other Liabilities Data

2019$2m
2018$4m
2017$7m
2016$6m
2015$23m
2014$21m
2013$39m
2012$15m
2011$40m